582 related articles for article (PubMed ID: 31052331)
1. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
[TBL] [Abstract][Full Text] [Related]
3. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
4. Natural Protein Intake in Children with Phenylketonuria: Prescription vs. Actual Intakes.
Pinto A; Daly A; Rocha JC; Ashmore C; Evans S; Ilgaz F; Hickson M; MacDonald A
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068761
[TBL] [Abstract][Full Text] [Related]
5. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
[TBL] [Abstract][Full Text] [Related]
6. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
[TBL] [Abstract][Full Text] [Related]
7. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
8. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
[TBL] [Abstract][Full Text] [Related]
9. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
10. Fifteen years of using a second stage protein substitute for weaning in phenylketonuria: a retrospective study.
Evans S; Daly A; MacDonald J; Pinto A; MacDonald A
J Hum Nutr Diet; 2018 Jun; 31(3):349-356. PubMed ID: 28940742
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
13. Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis.
Pinto A; Ilgaz F; Evans S; van Dam E; Rocha JC; Karabulut E; Hickson M; Daly A; MacDonald A
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630696
[TBL] [Abstract][Full Text] [Related]
14. Improved Eating Behaviour and Nutrient Intake in Noncompliant Patients with Phenylketonuria after Reintroducing a Protein Substitute: Observations from a Multicentre Study.
Green B; Rahman Y; Firman S; Adam S; Jenkinson F; Nicol C; Adams S; Dawson C; Robertson L; Dunlop C; Cozens A; Hubbard G; Stratton R
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480383
[TBL] [Abstract][Full Text] [Related]
15. Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.
Zori R; Ahring K; Burton B; Pastores GM; Rutsch F; Jha A; Jurecki E; Rowell R; Harding C
Mol Genet Metab; 2019; 128(1-2):92-101. PubMed ID: 31439512
[TBL] [Abstract][Full Text] [Related]
16. Neonatal phenylalanine wash-out in phenylketonuria.
Porta F; Ponzone A; Spada M
Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
[TBL] [Abstract][Full Text] [Related]
17. Protein substitute dosage in PKU: how much do young patients need?
MacDonald A; Chakrapani A; Hendriksz C; Daly A; Davies P; Asplin D; Hall K; Booth IW
Arch Dis Child; 2006 Jul; 91(7):588-93. PubMed ID: 16547085
[TBL] [Abstract][Full Text] [Related]
18. PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study.
Bratkovic D; Margvelashvili L; Tchan MC; Nisbet J; Smith N
Metabolism; 2022 Mar; 128():155116. PubMed ID: 34973284
[TBL] [Abstract][Full Text] [Related]
19. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
Gropper SS; Yannicelli S; White BD; Medeiros DM
Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for protein and amino acid intake in phenylketonuric patients.
Cockburn F; Clark BJ
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S125-9. PubMed ID: 8828627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
